Evidence map›Paper›PMID 35281576›Full record

ArticleInfection and drug resistance2022

N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms Formed by Clinical Strains of

Ewelina Piktel, Urszula Wnorowska, Joanna Depciuch, Dawid Łysik, Mateusz Cieśluk, Krzysztof Fiedoruk, Joanna Mystkowska, Magdalena Parlińska-Wojtan, Paul A Janmey, Robert Bucki

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Life (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. LC-MS/MS determination of pyocyanin-N-acetyl cysteine adduct: application for understanding Pseudomonas aeruginosa virulence factor neutralization.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ewelina PiktelDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, 15-222, Poland.ORCID 0000-0002-4531-7277
Urszula WnorowskaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, 15-222, Poland.
Joanna DepciuchInstitute of Nuclear Physic, Polish Academy of Sciences, Krakow, PL-31342, Poland.ORCID 0000-0003-0168-1701
Dawid ŁysikInstitute of Biomedical Engineering, Bialystok University of Technology, Bialystok, 15-351, Poland.ORCID 0000-0002-5370-0030
Mateusz CieślukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, 15-222, Poland.ORCID 0000-0002-5931-4376
Krzysztof FiedorukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, 15-222, Poland.
Joanna MystkowskaInstitute of Biomedical Engineering, Bialystok University of Technology, Bialystok, 15-351, Poland.ORCID 0000-0002-3386-146X
Magdalena Parlińska-WojtanInstitute of Nuclear Physic, Polish Academy of Sciences, Krakow, PL-31342, Poland.ORCID 0000-0001-5901-400X
Paul A JanmeyDepartment of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, 19102, USA.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, 15-222, Poland.ORCID 0000-0001-7664-9226
Medical University of Warsaw · PLBialystok University of Technology · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Extracellular polymeric substances (EPS) produced by bacteria, as they form a biofilm, determine the stability and viscoelastic properties of biofilms and prevent antibiotics from penetrating this multicellular structure. To date, studies demonstrated that an appropriate optimization of the chemistry and morphology of nanotherapeutics might provide a favorable approach to control their interaction with EPS and/or diffusion within the biofilm matrix. Targeting the biofilms' EPS, which in certain conditions can adopt liquid crystal structure, was demonstrated to improve the anti-biofilm activity of antibiotics and nanoparticles. A similar effect is achievable by interfering EPS' production by mucoactive agents, such as N-acetyl-cysteine (NAC). In our previous study, we demonstrated the nanogram efficiency of non-spherical gold nanoparticles, which due to their physicochemical features, particularly morphology, were noted to be superior in antimicrobial activity compared to their spherical-shaped counterparts. Methods: To explore the importance of EPS matrix modulation in achieving a suitable efficiency of peanut-shaped gold nanoparticles (AuP NPs) against biofilms produced by Results: We demonstrated that tested nanoparticles significantly inhibit the growth of mono- and mixed-species biofilms, particularly when combined with NAC. Notably, gold nanopeanuts were shown to decrease the viscosity and increase the creep compliance of Conclusion: We propose that peanut-shaped gold nanoparticles should be considered as a potent therapeutic agent against

Indexed as

bacteria biofilmcystic fibrosisgold nanoparticlesN-acetyl-cysteinenon-spherical nanoparticlesPseudomonas aeruginosa

Identifiers

PMID35281576
PMCPMC8906902
OpenAlexW4221073814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.